• Salarius Receives FDA Fast Track Designation for Seclidemstat americanpharmaceuticalreview
    December 18, 2019
    Salarius Pharmaceuticals announced its lead investigational drug candidate, Seclidemstat, has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA) for ...
  • Flex-Salarius merger to focus on epigenetic cancer therapies pharmaceutical-technology
    January 07, 2019
    Flex Pharmaceuticals has announced it has entered into a definitive merger agreement with Salarius Pharmaceuticals for an undisclosed sum. The board of directors of both companies have approved the merger.....
PharmaSources Customer Service